CD4 and neoplasm: NeoHELP-induced tumor control was dependent on the presence of CD4+ and CD8+ T cells, and neoHELP variants encoding the non-mutated, wild-type counterparts of either the CD4 or CD8 neoantigens caused reduced tumor control.